(Q34011810)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10954396%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

review article

1 reference

title

How high a dose of stimulant medication in adult attention deficit hyperactivity disorder? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10954396%20AND%20SRC:MED&resulttype=core&format=json

attention deficit hyperactivity disorder

9 November 2019

main subject

0 references

attention

1 reference

based on heuristic

inferred from title

adult attention deficit hyperactivity disorder

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10954396%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Julian N. Trollor

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10954396%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

author name string

P S Sachdev

series ordinal

1

1 reference

30 July 2017

J N Trollor

series ordinal

2

1 reference

30 July 2017

publication date

1 August 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10954396%20AND%20SRC:MED&resulttype=core&format=json

Australian and New Zealand Journal of Psychiatry

9 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10954396%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

volume

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10954396%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10954396%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

page(s)

645-650

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10954396%20AND%20SRC:MED&resulttype=core&format=json

Is attention-deficit hyperactivity disorder in adults a valid disorder?

9 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2000.00732.X

Patterns of psychiatric comorbidity, cognition, and psychosocial functioning in adults with attention deficit hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2000.00732.X

Pharmacotherapy of Adult Attention Deficit/Hyperactivity Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2000.00732.X

Diagnosis and treatment of minimal brain dysfunction in adults: a preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2000.00732.X

Methylphenidate effects on symptoms of attention deficit disorder in adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2000.00732.X

A double-blind, crossover comparison of methylphenidate and placebo in adults with childhood-onset attention-deficit hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2000.00732.X

Drug Therapy in Attention-Deficit Hyperactivity Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2000.00732.X

Practice parameters for the assessment and treatment of children, adolescents, and adults with attention-deficit/hyperactivity disorder. American Academy of Child and Adolescent Psychiatry

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2000.00732.X

Amphetamine-induced hypolocomotion in mice with more brain D2 dopamine receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2000.00732.X

Effects of d-amphetamine and methylphenidate on hyperactivity produced by neonatal 6-hydroxydopamine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2000.00732.X

Extracellular Concentration and In Vivo Recovery of Dopamine in the Nucleus Accumbens Using Microdialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2000.00732.X

A direct comparison of amphetamine-induced behaviours and regional brain dopamine release in the rat using intracerebral dialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2000.00732.X

Nonlinear relationship between impulse flow and dopamine released by rat midbrain dopaminergic neurons as studied by in vivo electrochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2000.00732.X

Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in the human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2000.00732.X

Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2000.00732.X

Changes in striatal D2-receptor density following chronic treatment with amphetamine as assessed with PET in nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2000.00732.X

Long-term stimulant treatment of children with attention-deficit hyperactivity disorder symptoms. A randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2000.00732.X

Pharmacokinetics and pharmacodynamics of (+)-threo-methylphenidate enantiomer in patients with hypersomnia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2000.00732.X

Pharmacokinetics of methylphenidate in hyperkinetic children

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2000.00732.X

Side effects of stimulant use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2000.00732.X

Stimulants and tic disorders: from dogma to data

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2000.00732.X

Pharmacotherapy of attention-deficit/hyperactivity disorder reduces risk for substance use disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2000.00732.X

Abuse of Prescribed Stimulant Medication by a 13-Year-Old Hyperactive Boy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2000.00732.X

Behavioural and biochemical effects of chronic amphetamine treatment in the vervet monkey

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2000.00732.X

Long-lasting psychotomimetic consequences of repeated low-dose amphetamine exposure in rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2000.00732.X

Repeated methylphenidate treatment induces behavioral sensitization and decreases protein kinase A and dopamine-stimulated adenylyl cyclase activity in the dorsal striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2000.00732.X

The late stage following continuous amphetamine administration to rats is correlated with altered dopamine but not serotonin metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2000.00732.X

Methylphenidate and brain dopamine neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2000.00732.X

Attention deficit hyperactivity disorder in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2000.00732.X

10.1080/J.1440-1614.2000.00732.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10954396%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference